Evidence map›Paper›PMID 33316781›Full record

ArticleAging2020

Circ_0005198 enhances temozolomide resistance of glioma cells through miR-198/TRIM14 axis.

Yanyao Deng, Hongwei Zhu, Le Xiao, Chao Liu, Xiangrui Meng

Open access · hybridAbstract read
In one paragraph

Article in Aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Role of non-coding RNAs in OOncology letters · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. [Circ_EPHB4 regulates temozolomide sensitivity in glioma cells through the miR-424-5p/Wnt3 axis].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. mMolecular neurobiology · 2024
    Article
  14. Review
  15. Review
  16. Article
  17. CircMolecular and cellular biology · 2023
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Yanyao DengDepartment of Neurology, The First Hospital of Changsha, Changsha 410005, Hunan, China.
Hongwei ZhuDepartment of Hepatopancreatobiliary Surgery, The Third Xiangya Hospital, Central South University, Changsha 410013, Hunan, China.
Le XiaoDepartment of Neurology, The First Hospital of Changsha, Changsha 410005, Hunan, China.
Chao LiuDepartment of Neurology, The First Hospital of Changsha, Changsha 410005, Hunan, China.
Xiangrui MengDepartment of Hepatopancreatobiliary Surgery, The Third Xiangya Hospital, Central South University, Changsha 410013, Hunan, China.
The First Hospital of Changsha · CNCentral South University · CNThird Xiangya Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circular RNAs (circRNAs) are associated with chemoresistance in many cancers. However, the function of circ_0005198 in the temozolomide (TMZ) resistance of glioma has not been well elucidated. Here, we demonstrated that circ_0005198 was considerably up-regulated in glioma tissues, serum samples and TMZ-resistant glioma cells. Silencing of circ_0005198 restrained TMZ resistance, restricted the proliferation and facilitated the apoptosis of TMZ-resistant glioma cells. MiR-198 could be sponged by circ_0005198, and we demonstrated that the effect of circ_0005198 on the progression of TMZ-resistant glioma cells was attributed to the inhibition of miR-198 activity. Moreover, TRIM14 was a target of miR-198 and silencing of TRIM14 hindered TMZ resistance and suppressed the progression of TMZ-resistant glioma cells, while TRIM14 over-expression rescued the inhibiting effect of miR-198 over-expression. We conclude that circ_0005198-miR-198-TRIM14 regulatory pathway is critical to TMZ resistance of glioma.

Indexed as

Antineoplastic Agents, AlkylatingApoptosisBrain NeoplasmsCell Line, TumorCell ProliferationDrug Resistance, NeoplasmGene Expression Regulation, NeoplasticGliomaHumansIntracellular Signaling Peptides and ProteinsMicroRNAsRNA, CircularTemozolomideTripartite Motif ProteinsUp-RegulationAntineoplastic Agents, AlkylatingIntracellular Signaling Peptides and ProteinsMicroRNAsMIRN198 microRNA, humanRNA, CircularTemozolomideTRIM14 protein, humanTripartite Motif Proteinscirc_0005198gliomamiR-198TMZ resistanceTRIM14

Identifiers

PMID33316781
PMCPMC7880338
OpenAlexW3110900883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.